Stockscreener 앱 받기
31.70
4.98%
-1.66
시간 외 거래:
31.56
-0.14
-0.44%
Tg Therapeutics Inc 주식(TGTX)의 최신 뉴스
TG Therapeutics (NASDAQ:TGTX) Rating Lowered to Sell at StockNews.com - MarketBeat
Nisa Investment Advisors LLC Buys 2,803 Shares of TG Therapeutics, Inc. (NASDAQ:TGTX) - Defense World
Trading (TGTX) With Integrated Risk Controls - Stock Traders Daily
All You Need to Know About TG Therapeutics (TGTX) Rating Upgrade to Buy - MSN
TG Therapeutics (NASDAQ:TGTX) Stock Price Up 6.8%Here's What Happened - MarketBeat
Why TGTX Stock Is Rallying Today - MSN
TG Therapeutics: Entering 2025 With Increased Investor Expectations (NASDAQ:TGTX) - Seeking Alpha
Cantor Fitzgerald Weighs in on TG Therapeutics FY2025 Earnings - Defense World
Assenagon Asset Management S.A. Decreases Stock Position in TG Therapeutics, Inc. (NASDAQ:TGTX) - MarketBeat
TG Therapeutics: 2025 Revenues Will Smash Expectations (NASDAQ:TGTX) - Seeking Alpha
12 Hot Stocks to Buy According to Analysts - Insider Monkey
Here’s Why Analysts Are Bullish on TG Therapeutics, Inc. (TGTX) - Insider Monkey
TG Therapeutics (TGTX) Moves 7.5% Higher: Will This Strength Last? - MSN
(TGTX) Trading Signals - Stock Traders Daily
Brookstone Capital Management Acquires 624 Shares of TG Therapeutics, Inc. (NASDAQ:TGTX) - Defense World
FY2024 EPS Forecast for TG Therapeutics Increased by Analyst - Defense World
Is TG Therapeutics Inc. (TGTX) Among Tuesday’s Top Gainers? - MSN
TG Therapeutics FY2024 EPS Forecast Raised by HC Wainwright - MarketBeat
TG Therapeutics Provides Preliminary Fourth Quarter and Full-Year Financial Results in SEC Filing - Defense World
TG Therapeutics: Cash Positive But Playing Defense (Rating Downgrade) (NASDAQ:TGTX) - Seeking Alpha
TG Therapeutics FY2025 EPS Forecast Raised by HC Wainwright - MarketBeat
TG Therapeutics' (TGTX) "Buy" Rating Reiterated at HC Wainwright - MarketBeat
TGTX Announces 2024 Preliminary Results, 2025 Goals, Shares Rise - MSN
Exploring Three High Growth Tech Stocks In The United States - Yahoo Finance
Have Insiders Sold TG Therapeutics Shares Recently? - Simply Wall St
Expert Outlook: TG Therapeutics Through The Eyes Of 5 Analysts - Benzinga
10 Firms Post Impressive Gains on Tuesday - Insider Monkey
TG Therapeutics Reports Strong Revenue and Future Goals - TipRanks
TG Therapeutics Shares Climb 7% as Sales Grow for Multiple Sclerosis Drug - MarketWatch
TG Therapeutics Provides Preliminary Fourth Quarter and - GlobeNewswire
TG Therapeutics (NASDAQ:TGTX) Shares Gap UpHere's Why - MarketBeat
TG Therapeutics projects $540 million in 2025 revenue By Investing.com - Investing.com Nigeria
What's Going On With TG Therapeutics Stock Tuesday? - Benzinga
TG Therapeutics says 2024 Briumvi sales topped expectations - MSN
TG Therapeutics stock rises on strong Q4 and full-year revenue - Investing.com Nigeria
TG Therapeutics stock rises on strong Q4 and full-year revenue By Investing.com - Investing.com South Africa
TG Therapeutics stock gains on Briumvi sales (TGTX:NASDAQ) - Seeking Alpha
TG Therapeutics projects $540 million in 2025 revenue - Investing.com
TG Therapeutics' BRIUMVI Hits $310M Revenue in 2024, Projects 75% Growth for 2025 - StockTitan
Brokerages Set TG Therapeutics, Inc. (NASDAQ:TGTX) PT at $40.67 - MarketBeat
TG Therapeutics, Inc. (NASDAQ:TGTX) Receives Consensus Rating of “Moderate Buy” from Brokerages - Defense World
TG Therapeutics: Subcutaneous Briumvi Data A Key Near-Term Catalyst (NASDAQ:TGTX) - Seeking Alpha
JPMorgan Chase & Co. Buys 270,286 Shares of TG Therapeutics, Inc. (NASDAQ:TGTX) - MarketBeat
Should You Invest in TG Therapeutics (TGTX)? - Insider Monkey
TG Therapeutics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference - The Manila Times
3.95%
2.39%
자본화:
|
볼륨(24시간):